EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery

Wenhan Wang, Kangfu Chen, Zongjie Wang iD

Advanced Science · 2026

DOI: 10.1002/advs.202517617 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Science, 2026. Verfasst von Wenhan Wang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Chan Zuckerberg Biohub Chicago, Chicago, IL, 60607, USA. Hauptthemen laut MEDLINE: RNA, Small Interfering, Nanoparticles, Class I Phosphatidylinositol 3-Kinases. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 54 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: International Society for Advancement of Cytometry, Chan Zuckerberg Biohub, Chan Zuckerberg Initiative.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticles (LNPs) are useful carriers for therapeutic siRNA delivery, yet their clinical efficacy remains constrained by insufficient cellular uptake. Here, using a genome‐wide CRISPR knockout screen, multiple genetic modulators of LNP uptake is uncovered, with PIK3CA emerging as a top druggable target. Pharmacologic inhibition of PIK3CA with BAY1082439 – a clinically evaluated small molecule – significantly enhances LNP uptake, siRNA delivery, and gene silencing across diverse epithelial cancer cell lines in vitro. Co‐administration of BAY1082439 with siRNA‐loaded LNPs also better suppressed tumor growth and reduced liver inflammation in vivo, respectively. These findings establish PIK3CA inhibition as a broadly applicable strategy to boost LNP‐mediated RNA interference and highlight the promise of combining functional genomics with nanomaterials to advance RNA‐based therapeutics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, Small InterferingNanoparticlesClass I Phosphatidylinositol 3-KinasesHumansAnimalsMiceCell Line, TumorClustered Regularly Interspaced Short Palindromic RepeatsLipidsCRISPR-Cas SystemsLiposomes

Stichwörter der Autor:innen

CRISPRcancer treatmentfunctional genomicsinflammatory diseaseslipid nanoparticles, siRNA

Substanzen

RNA, Small InterferingClass I Phosphatidylinositol 3-KinasesPIK3CA protein, humanLipid NanoparticlesLipidsLiposomes

Autor:innen und Institutionen

  • Chan Zuckerberg Biohub Chicago, Chicago, IL, 60607, USA.
  • Department of Biomedical Engineering, McCormick School of Engineering, Northwestern University, Evanston, IL, 60208, USA.
  • School of Integrated Circuits and Electronics, Beijing Institute of Technology, Beijing, 100081, P. R. China.

ORCID-Profile: Zongjie Wang

Förderung

  • International Society for Advancement of Cytometry
  • Chan Zuckerberg Biohub
  • Chan Zuckerberg Initiative

Zitieren

APA

Wang, W., Chen, K., & Wang, Z. (2026). Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery. Advanced Science. https://doi.org/10.1002/advs.202517617

Vancouver

Wang W, Chen K, Wang Z. Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery. Advanced Science. 2026. doi:10.1002/advs.202517617

BibTeX
@article{Wang2026,
  author = {Wang, Wenhan and Chen, Kangfu and Wang, Zongjie},
  title = {Genome‐Wide CRISPR Screen Reveals PIK3CA Inhibition Enhances Lipid Nanoparticle‐Mediated siRNA Delivery},
  journal = {Advanced Science},
  year = {2026},
  doi = {10.1002/advs.202517617}
}
Kostenlos starten →